Group A and C Meningococcal Polysaccharide Vaccine (Walvax)

A、C群脑膜炎球菌多糖疫苗(沃森生物)

Report date: 2024/04/23 15:57:06

Base Information

Drug NameGroup A and C Meningococcal Polysaccharide Vaccine (Walvax)
Drug Alias NameMeningococcal group A, C bivalent polysaccharide conjugate vaccine (Freeze dried, Walvax)Group A and C Meningococcal Polysaccharide Conjugate Vaccine (Walvax)沃尔平
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Conjugated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal Infections
Global Approved IndicationsMeningococcal Infections
Approved Indications in ChinaMeningococcal Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2012/03/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co LtdWalvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH03
Related LinksN/A